• Intellectual property and technology commercialization manager• Negotiated and closed over 75 IP licensing deals• My tasks included intellectual property evaluation and triage, patent prosecution management, commercialization plan development, technology marketing, negotiation of complex technology licenses, post-deal compliance, and much more• Advised on and negotiated intellectual property matters throughout the institution, including industry-sponsored research agreements, charitable and foundation research grant agreements, and manufacturing agreements

• Provided writing, editing, and graphic design support for research, multi-project, and multi-institution NIH grant applications

• Directed course in translational psychiatry• Managed initial set up of neurochemistry laboratory and behavioral core facility, including development of advertising materials for behavioral core facility

• Coordinated collaborations with two biotech industry partners• Created and maintained three relational databases to manage longitudinal animal studies • Developed expertise in preclinical model development for neurological diseaseMy PhD thesis included the following major projects: (1) the first preclinical trial examining the utility of full-length insulin like growth factor I in the Mecp2 knockout mouse model of Rett Syndrome (RTT); (2) detailed characterization of the R255X nonsense mutation mouse model of RTT, including mTOR pathway abnormalities; and (3) in vitro proof-of-concept study demonstrating nonsense-mutation suppression therapy in the R255X model.

• Designed and performed preclinical studies for ophthalmic indications • Conducted high-throughput behavioral assays in mouse models of neurological disease • Developed expertise in knockout mouse characterization